Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_provenance.
- NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_assertion description "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_provenance.
- NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_assertion evidence source_evidence_literature NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_provenance.
- NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_assertion SIO_000772 19877382 NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_provenance.
- NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_assertion wasDerivedFrom befree-2016 NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_provenance.
- NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_assertion wasGeneratedBy ECO_0000203 NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_provenance.
- befree-2016 importedOn "2016-02-19" NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_provenance.